The pharmaceutical industry is undergoing a paradigm shift, as Artificial Intelligence (AI) becomes a central force in transforming every stage of the drug lifecycle, from discovery to post-market performance. Among its most disruptive applications, AI in drug commercialization is redefining how therapies are launched, marketed, and delivered to patients. In a sector historically burdened by long timelines, escalating costs, and unpredictable market access barriers, AI brings a data-driven, predictive, and personalized approach that enhances decision-making and ensures commercial success.
As the healthcare ecosystem becomes increasingly complex, with expandin...
